Recursion Pharmaceuticals
company
Funding Round
Series D
Money Raised
$ 239M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Advantage Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Feb 12, 2018 | Series B | 0 | Advantage Capital | Detail |
| Oct 4, 2017 | Series B | $ 60M | Advantage Capital | Detail |
| Nov 25, 2015 | Series A | 0 | Advantage Capital | Detail |
| Feb 25, 2015 | Grant | $ 1.50M | National Institutes of Health | Detail |
